Nexviazyme (Avalglucosidase alfa-ngpt)

Nexviazyme is a hydrolytic lysosomal glycogen-specific enzyme used to treat patients aged 12 months (1 year) and older with late-onset Pompe disease, which is also known as LOPD.

Recommended Dosage: Before the use of Nexviazyme injection, consider pretreating with antipyretics, antihistamines, or corticosteroids. This medicinal product must be reconstituted and diluted before use.

Nexviazyme is administered as an intravenous infusion. For those weighing: 

• ≥30 kg, the proposed dosage is 20 mg/kg (of actual body weight) every 2 weeks
• <30 kg, the proposed dosage is 40 mg/kg (of actual body weight) every 2 weeks.

The initial prescribed infusion rate is 1 mg/kg/hour. Slowly enhance the infusion rate every 30 minutes in case there are no signs and symptoms of infusion-associated reactions (IARs).

• In case serious hypersensitivity reactions occur, Nexviazyme needs to be discontinued promptly suitable medical treatment should be started. The risk and benefits of reusing the medication after serious hypersensitivity reactions (including anaphylaxis) need to be considered.
• Those with an acute underlying disease while Nexviazyme infusion appears to be at higher risk for infusion-associated reactions (IARs). Those with advanced Pompe disease (PD) may have compromised cardiac/respiratory function, which may put them at a greater risk of serious complications from infusion-associated reactions.
• More frequent evaluations of vitals need to be performed during avalglucosidase alfa infusion in those prone to fluid volume overload, or those with acute underlying respiratory illness. Certain patients may need protracted observation times.  

What documents are required to import NEXVIAZYME to India?

NEXVIAZYME (avalglucosidase alfa-ngpt) injections can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

1. A valid prescription from a qualified doctor.
2. Patients diagnostic reports
3. Patients ID Proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

1. A valid prescription from the Doctor
2. Import permit if applicable

Is NEXVIAZYME available in India?

NEXVIAZYME (avalglucosidase alfa-ngpt injection) is a prescription drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:

• Availability of Nexviazyme in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• Medicine Price.
• Finding genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

NEXVIAZYME can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of NEXVIAZYME (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Nexviazyme 100 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing NEXVIAZYME (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Nexviazyme®?

Avalglucosidase alfa-ngpt is the Generic Name for the trade name drug Nexviazyme®.

What is the Manufacturer’s Name of Nexviazyme®?

Nexviazyme® is manufactured by Sanofi.

Is Nexviazyme® approved by the FDA?

Yes, Nexviazyme® is approved by the FDA. Date of first approval: August 06, 2021.

Where can I get Nexviazyme® at the best price in India?

To get the best Nexviazyme price in India, kindly get in touch with Urgent Meds (a WHO GDP & ISO 9001:2008 certified company). For Nexviazyme®, a valid medical prescription is required from your treating physician.

What is the dosage and form of Nexviazyme® supplied?

Nexviazyme® is supplied as an injection: 100 mg of avalglucosidase alfa-ngpt as a lyophilized powder in a single-dose vial for reconstitution for intravenous administration.

What are the most common side effects of Nexviazyme®?

The most common side effects of Nexviazyme® are headache, vomiting, fatigue, diarrhea, dizziness, nausea, arthralgia, myalgia, erythema, pruritus, dyspnea, paresthesia, and urticaria.

How much does Nexviazyme® cost in India?

The Nexviazyme cost in India is less and can vary. In order to procure this medication authentically, you can Call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.

What are the storage conditions of Nexviazyme®?

Refrigerate vials at 36°F to 46°F (2°C to 8°C). Do not use this medicine after the expiration date on the vial.

Is it safe to buy Nexviazyme® online from India?

Yes, one can buy Nexviazyme from India at the best price from Urgent Meds if the drug Nexviazyme has not been approved or is not available in your home country. We can help facilitate the supply of Nexviazyme.

For more information, please contact +1-647-818-4196 or email us at info@urgentmeds.in.